• Tue, August 10, 2021
Joel Beatty Downgraded (ARCT) to Sell on, Aug 10th, 2021
Joel Beatty of Baird, Downgraded "Arcturus Therapeutics Holdings Inc." (ARCT) to Sell on, Aug 10th, 2021.
Joel has made no other calls on ARCT in the last 4 months.
There is 1 other peer that has a rating on ARCT. Out of the 1 peers that are also analyzing ARCT, 0 agree with Joel's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joel
- Gena Wang of "Barclays" Downgraded from Hold to Sell and Decreased Target to $25 on, Monday, June 21st, 2021
Like: 👍
